Magnolia Solar Corp (MGLT) 0.0600 $MGLT Ecoark Holdings,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Magnolia Solar Corp (MGLT) 0.0600 $MGLT

Ecoark Holdings, Inc. Symbol Changes to EARK
GlobeNewswire - Fri Apr 22, 12:05PM CDT
Ecoark Holdings, Inc. (OTCQB:EARK), a technology company providing business solutions to a wide range of clients, announced today that the company is now trading under the new symbol "EARK," following the merger with Magnolia Solar (OTCQB:MGLT) and name to change to Ecoark Holdings, Inc.. All stock trading, filings, and market related information will be reported under EARK.

Magnolia Solar is Exploring Growth in the Solar Installation Business in Domestic and the International Market
GlobeNewswire - Tue Sep 22, 9:03AM CDT
Magnolia Solar Corporation (OTCQB:MGLT) ("Magnolia Solar" announced today that it is exploring growth in the installation business. This sector of the solar business is growing very rapidly. Magnolia continues to have discussions with solar installers that are privately held and are interested in getting listed on a US exchange.

Magnolia Solar is Presenting Recent Accomplishments at the Annual MRS Spring Conference in San Francisco, CA
GlobeNewswire - Thu Apr 09, 9:00AM CDT
Magnolia Solar Corporation (OTCQB:MGLT) ("Magnolia Solar" announced today that one of its senior scientists, Dr. Gopal Pethuraja, is attending and presenting at the Annual Material Research Society (MRS) Spring Meeting in San Francisco, CA. The meeting is scheduled this week April 6-10, 2015.

Magnolia Solar Recipient of Three US Patents for Lightweight Flexible Solar Cells
GlobeNewswire - Thu Apr 02, 9:00AM CDT
Magnolia Solar Corporation (OTCQB:MGLT) ("Magnolia Solar" announced today that its wholly owned subsidiary, Magnolia Solar, Inc., has been recently awarded three additional patents by the United States Patent and Trademark Office (USPTO). Magnolia Solar, Inc. is the assignee of US Patents No. 8,921,687, 8,969,711, and 8,981,207. These three recently-issued patents describe and protect Magnolia's innovations in the field of high-performance, lightweight flexible solar cells for photovoltaic applications, and expands the intellectual property portfolio to five issued patents.

Magnolia Solar Recipient of US Patent on High-Efficiency Multi-Junction Solar Cells
GlobeNewswire - Tue Dec 16, 7:06AM CST
Magnolia Solar Corporation (OTCQB:MGLT) ("Magnolia Solar" announced today that its wholly owned subsidiary, Magnolia Solar, Inc., was recently issued a patent by the United States Patent and Trademark Office (USPTO). Magnolia Solar, Inc. is the assignee of US Patent No. 8,895,838 which describes an improved multi-junction solar cell structure. The patent issued on November 25, 2014 and is designed to protect and enhance Magnolia's innovations in the field of high-performance and flexible solar cells for photovoltaic applications.

Magnolia Solar Recipient of US Patent on Roll-to-Roll Flexible Solar Cell Production
GlobeNewswire - Tue Nov 25, 7:00AM CST
Magnolia Solar Corporation (OTCQB:MGLT) ("Magnolia Solar" announced today that its wholly owned subsidiary, Magnolia Solar, Inc., was recently issued a patent by the United States Patent and Trademark Office (USPTO). Magnolia Solar, Inc. is the assignee of US Patent No. 8,865,506 which describes a roll-to-roll process method for fabricating solar cells. The patent issued on October 21, 2014 and is designed to protect and enhance Magnolia's innovations in the field of flexible photovoltaics.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading